RS
Rama Shanker
About Rama Shanker
Data last updated:
Rama Shanker is a Director at Pure And Cure Healthcare Private Limited (since 2014) and Director at Amazing Research Laboratories Limited (since 2017). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹1,781 Cr; the largest is Pure And Cure Healthcare Private Limited at ₹1,781 Cr (FY 2026). Earlier, Rama Shanker was a Director at Unosource Pharma Limited (2024–2026) and Director at Akums Healthcare Limited (2020–2026) and 2 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Pure And Cure Healthcare Private Limited U24232DL2005PTC266385 | Director | 18 Sep 2014 | 2005 | ₹1,781 Cr (FY 2026) | Active |
 Amazing Research Laboratories Limited U99999DL1998PLC095297 | Director | 20 May 2017 | 1998 | ₹3.5 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Unosource Pharma Limited U24233DL2013PLC262364 | Director | 29 May 2024 | 2013 | ₹154 Cr (FY 2026) | Active |
 Akums Healthcare Limited U24304DL2020PLC375098 | Director | 29 Dec 2020 | 2020 | ₹80.52 Cr (FY 2026) | Active |
| Akum Impex Llp AAA-3138 | Designated Partner | 30 Jan 2020 | 2010 | Strike Off | |
 Akums Lifesciences Limited U24231CH1996PLC017755 | Director | 31 Mar 2021 | 1996 | ₹223 Cr (FY 2023) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rama Shanker
| Name | DIN | Company | Designation |
|---|---|---|---|
| Gaurav | Pure And Cure Healthcare Private Limited | Company Secretary | |
| Gopi Nath Sahu | 02877564 | Pure And Cure Healthcare Private Limited | Whole-Time Director |
| Raj Kumar Jha | 11748406 | Pure And Cure Healthcare Private Limited | Additional Director |
| Satwinder Singh | 00164903 | Pure And Cure Healthcare Private Limited | Director |
| Satya Prakash | 06724729 | Pure And Cure Healthcare Private Limited | Whole-Time Director |
| Suman | 02326675 | Pure And Cure Healthcare Private Limited | Additional Director |
| Rajesh Verma | 00330605 | Amazing Research Laboratories Limited | Director |
| Rashmi Gupta | 02583595 | Amazing Research Laboratories Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rama Shanker
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rama Shanker
Rama Shanker currently holds 2 directorships: Pure And Cure Healthcare Private Limited (Director, since 18 Sep 2014, revenue ₹1,781 Cr (FY 2026)); Amazing Research Laboratories Limited (Director, since 20 May 2017, revenue ₹3.5 Lakh (FY 2025)).
Rama Shanker was first appointed on 18 Sep 2014 as Director at Pure And Cure Healthcare Private Limited. The most recent appointment on record is 29 May 2024 at Unosource Pharma Limited.
The 2 current companies of Rama Shanker that report revenue have a combined latest revenue of ₹1,781 Cr: Pure And Cure Healthcare Private Limited ₹1,781 Cr (FY 2026); Amazing Research Laboratories Limited ₹3.5 Lakh (FY 2025).
Rama Shanker held 4 earlier board appointments: Unosource Pharma Limited (Director, 29 May 2024 to 11 Feb 2026); Akums Healthcare Limited (Director, 29 Dec 2020 to 10 Feb 2026); Akum Impex Llp (Designated Partner, 30 Jan 2020 to 30 Sep 2022); Akums Lifesciences Limited (Director, from 31 Mar 2021).
The current boards of Rama Shanker's companies include Gaurav (Pure And Cure Healthcare Private Limited), Gopi Nath Sahu (Pure And Cure Healthcare Private Limited), Raj Kumar Jha (Pure And Cure Healthcare Private Limited), Satwinder Singh (Pure And Cure Healthcare Private Limited), Satya Prakash (Pure And Cure Healthcare Private Limited), Suman (Pure And Cure Healthcare Private Limited), among others.